{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T20:15:05Z","timestamp":1760300105496},"reference-count":60,"publisher":"Bentham Science Publishers Ltd.","issue":"7","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["MC"],"published-print":{"date-parts":[[2019,10,14]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p> Malaria remains a common life-threatening infectious disease across the\nglobe due to the development of resistance by Plasmodium parasite against most antimalarial\ndrugs. The situation demands new and effective drug candidates against Plasmodium.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objectives:<\/jats:title>\n<jats:p>The objective of this study is to design, synthesize and test novel quinoline based\nmolecules against the malaria parasite.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>C2 and C8 modified quinoline analogs obtained via C-H bond functionalization approach\nwere synthesized and evaluated for inhibition of growth of P. falciparum grown in human\nred blood cells using SYBR Green microtiter plate based screening. Computational molecular\ndocking studies were carried out with top fourteen molecules using Autodoc software.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>The biological evaluation results revealed good activity of quinoline-8-acrylate 3f (IC50\n14.2 \u00b5M), and the 2-quinoline-\u03b1-hydroxypropionates 4b (IC50 6.5 \u00b5M), 4j (IC50 5.5 \u00b5M) and 4g\n(IC50 9.5 \u00b5M), against chloroquine sensitive Pf3D7 strain. Top fourteen molecules were screened\nalso against chloroquine resistant Pf INDO strain and the observed resistant indices were found to\nlie between 1 and 7.58. Computational molecular docking studies indicated a unique mode of binding\nof these quinolines to Falcipain-2 and heme moiety, indicating these to be the probable targets\nof their antiplasmodial action.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>An important finding of our work is the fact that unlike Chloroquine which shows a\nresistance Index of 15, the resistance indices for the most promising molecules studied by us were\nabout one indicating equal potency against drug sensitive and resistant strains of the malaria parasite.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1573406414666181015144413","type":"journal-article","created":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T12:08:13Z","timestamp":1539691693000},"page":"790-800","update-policy":"http:\/\/dx.doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Evaluation of Antiplasmodial Potential of C2 and C8 Modified Quinolines: in vitro and in silico Study"],"prefix":"10.2174","volume":"15","author":[{"given":"Rakesh","family":"Kumar","sequence":"first","affiliation":[{"name":"Natural Product Chemistry and Process Development Division, CSIR-Institute of Himalayan Bioresource Technology, Palampur, Himachal Pradesh 176 061, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ritika","family":"Sharma","sequence":"additional","affiliation":[{"name":"Natural Product Chemistry and Process Development Division, CSIR-Institute of Himalayan Bioresource Technology, Palampur, Himachal Pradesh 176 061, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inder","family":"Kumar","sequence":"additional","affiliation":[{"name":"Natural Product Chemistry and Process Development Division, CSIR-Institute of Himalayan Bioresource Technology, Palampur, Himachal Pradesh 176 061, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pooja","family":"Upadhyay","sequence":"additional","affiliation":[{"name":"Malaria Drug Discovery Laboratory, International Centre for Genetic Engineering and Biotechnology, Aruna Asaf Ali Marg, New Delhi, 110067, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ankit Kumar","family":"Dhiman","sequence":"additional","affiliation":[{"name":"Natural Product Chemistry and Process Development Division, CSIR-Institute of Himalayan Bioresource Technology, Palampur, Himachal Pradesh 176 061, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rohit","family":"Kumar","sequence":"additional","affiliation":[{"name":"Natural Product Chemistry and Process Development Division, CSIR-Institute of Himalayan Bioresource Technology, Palampur, Himachal Pradesh 176 061, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rakesh","family":"Kumar","sequence":"additional","affiliation":[{"name":"Natural Product Chemistry and Process Development Division, CSIR-Institute of Himalayan Bioresource Technology, Palampur, Himachal Pradesh 176 061, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rituraj","family":"Purohit","sequence":"additional","affiliation":[{"name":"Academy of Scientific and Innovative Research, CSIR-Institute of Himalayan Bioresource Technology, Palampur, Himachal Pradesh-176 061, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dinkar","family":"Sahal","sequence":"additional","affiliation":[{"name":"Malaria Drug Discovery Laboratory, International Centre for Genetic Engineering and Biotechnology, Aruna Asaf Ali Marg, New Delhi, 110067, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Upendra","family":"Sharma","sequence":"additional","affiliation":[{"name":"Natural Product Chemistry and Process Development Division, CSIR-Institute of Himalayan Bioresource Technology, Palampur, Himachal Pradesh 176 061, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","unstructured":"Geneva: World Health Organization."},{"key":"ref=2","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0163-7258(98)00012-6","volume":"79","author":"Foley M.","year":"1998","unstructured":"Foley M.; Tilley L.; Quinoline Antimalarials: Mechanisms of action and resistance and prospects for new agents. Pharmacol Ther 1998,79,55-87","journal-title":"Pharmacol Ther"},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nrmicro3138","volume":"11","author":"Flannery E.L.","year":"2013","unstructured":"Flannery E.L.; Chatterjee A.K.; Winzeler E.A.; Antimalarial drug-discovery approaches and progress towards new medicines. Nat Rev Microbiol 2013,11,849-862","journal-title":"Nat Rev Microbiol"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/med.20062","volume":"27","author":"Vangapandu S.","year":"2007","unstructured":"Vangapandu S.; Jain M.; Kaur K.; Patil P.; Patel S.R.; Jain R.; Recent advances in antimalarial drug development. Med Res Rev 2007,27,65-107","journal-title":"Med Res Rev"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/nrmicro2331","volume":"8","author":"Dondorp A.M.","year":"2010","unstructured":"Dondorp A.M.; Yeung S.; White L.; Nguon C.; Day N.P.J.; Socheat D.; von Seidlein L.; Artemisinin resistance: Current status and scenarios for containment. Nat Rev Microbiol 2010,8,272-280","journal-title":"Nat Rev Microbiol"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1172\/JCI21682","volume":"113","author":"White N.J.","year":"2004","unstructured":"White N.J.; Antimalarial drug resistance. J Clin Invest 2004,113,1084-1092","journal-title":"J Clin Invest"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1021\/jm201216y","volume":"55","author":"Sharma N.","year":"2012","unstructured":"Sharma N.; Mohanakrishnan D.; Shard A.; Sharma A.; Saima; Sinha, A.K.; Sahal, D. Stilbene-Chalcone hybrids: Design, synthesis, and evaluation as a new class of antimalarial scaffolds that trigger cell death through stage specific apoptosis. J Med Chem 2012,55,297-311","journal-title":"J Med Chem"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"B233","DOI":"10.1016\/j.vaccine.2013.02.040","volume":"31","author":"Birkett A.J.","year":"2013","unstructured":"Birkett A.J.; Moorthy V.S.; Loucq C.; Chitnis C.E.; Kaslow D.C.; Malaria vaccine R","journal-title":"Vaccine"},{"key":"ref=9","author":"Lopez A.E.","unstructured":"Lopez A.E.;  Privileged scaffolds in medicinal chemistry: Design,\nsynthesis, evaluation. Royal Soc. Chem. (London),  2015, November,\n132-146."},{"key":"ref=10","author":"Musiol R.","unstructured":"Musiol R.; Magdziarz T.; Kurczyk A.;  Quinoline scaffold as a\nprivileged substructure in antimicrobial drugs. Science against microbial\npathogens: Communicating current research and technological\nadvances, 2011, M\u00e9ndez-Vilas, A. (Ed.), pp. 72-83."},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsps.2012.03.002","volume":"21","author":"Marella A.","year":"2013","unstructured":"Marella A.; Tanwar O.P.; Saha R.; Ali M.R.; Srivastava S.; Akhter M.; Shaquiquzzaman M.; Alam M.M.; Quinoline: A versatile heterocyclic. Saudi Pharm J 2013,21,1-12","journal-title":"Saudi Pharm J"},{"key":"ref=12","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1016\/j.ejmech.2010.04.011","volume":"45","author":"Kaur K.","year":"2010","unstructured":"Kaur K.; Jain M.; Reddy R.P.; Jain R.; Quinolines and structurally related heterocycles as antimalarials. Eur J Med Chem 2010,45,3245-3264","journal-title":"Eur J Med Chem"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"5098","DOI":"10.1016\/j.bmc.2014.12.018","volume":"23","author":"Vandekerckhove S.","year":"2015","unstructured":"Vandekerckhove S.; D\u2019hooghe M.; Quinoline-based antimalarial hybrid compounds. Bioorg Med Chem 2015,23,5098-5119","journal-title":"Bioorg Med Chem"},{"key":"ref=14","doi-asserted-by":"crossref","DOI":"10.1385\/1592591116","author":"Rosenthal P.J.","year":"2001","unstructured":"Rosenthal P.J.;  Antimalarial chemotherapy: Mechanisms of action, resistance, and new directions in drug discovery 2001","journal-title":"Antimalarial chemotherapy: Mechanisms of action, resistance, and new directions in drug discovery"},{"key":"ref=15","first-page":"295","volume":"25","author":"Singh S.K.","year":"2014","unstructured":"Singh S.K.; Singh S.; A brief history of quinoline as antimalarial agents. Int J Pharm Sci Rev Res 2014,25,295-302","journal-title":"Int J Pharm Sci Rev Res"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/1475-2875-10-144","volume":"10","author":"Achan J.","year":"2011","unstructured":"Achan J.; Talisuna A.O.; Erhart A.; Yeka A.; Tibenderana J.K.; Baliraine F.N.; Rosenthal P.J.; D\u2019Alessandro U.; Quinine, an old anti-malarial drug in a modern world: Role in the treatment of malaria. Malar J 2011,10,144-144","journal-title":"Malar J"},{"key":"ref=17","doi-asserted-by":"crossref","first-page":"64","DOI":"10.4103\/0975-7406.67002","volume":"2","author":"Bawa S.","year":"2010","unstructured":"Bawa S.; Kumar S.; Drabu S.; Kumar R.; Structural modifications of quinoline-based antimalarial agents: Recent developments. J Pharm Bioallied Sci 2010,2,64-71","journal-title":"J Pharm Bioallied Sci"},{"key":"ref=18","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nature14451","volume":"522","author":"Baragana B.","year":"2015","unstructured":"Baragana B.; Hallyburton I.; Lee M.C.S.; Norcross N.R.; Grimaldi R.; Otto T.D.; Proto W.R.; Blagborough A.M.; Meister S.; Wirjanata G.; Ruecker A.; Upton L.M.; Abraham T.S.; Almeida M.J.; Pradhan A.; Porzelle A.; Martinez M.S.; Bolscher J.M.; Woodland A.; Norval S.; Zuccotto F.; Thomas J.; Simeons F.; Stojanovski L.; Osuna-Cabello M.; Brock P.M.; Churcher T.S.; Sala K.A.; Zakutansky S.E.; Jimenez-Diaz M.B.; Sanz L.M.; Riley J.; Basak R.; Campbell M.; Avery V.M.; Sauerwein R.W.; Dechering K.J.; Noviyanti R.; Campo B.; Frearson J.A.; Angulo-Barturen I.; Ferrer-Bazaga S.; Gamo F.J.; Wyatt P.G.; Leroy D.; Siegl P.; Delves M.J.; Kyle D.E.; Wittlin S.; Marfurt J.; Price R.N.; Sinden R.E.; Winzeler E.A.; Charman S.A.; Bebrevska L.; Gray D.W.; Campbell S.; Fairlamb A.H.; Willis P.A.; Rayner J.C.; Fidock D.A.; Read K.D.; Gilbert I.H.; A novel multiple-stage antimalarial agent that inhibits protein synthesis. Nature 2015,522,315-320","journal-title":"Nature"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/nm.2471","volume":"17","author":"Tu Y.","year":"2011","unstructured":"Tu Y.; The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine. Nat Med 2011,17,1217-1220","journal-title":"Nat Med"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1475-2875-13-7","volume":"13","author":"Banek K.","year":"2014","unstructured":"Banek K.; Lalani M.; Staedke S.G.; Chandramohan D.; Adherence to artemisinin-based combination therapy for the treatment of malaria: A systematic review of the evidence. Malar J 2014,13,7","journal-title":"Malar J"},{"key":"ref=21","author":"Sinclair D.","year":"2009","unstructured":"Sinclair D.; Zani B.; Donegan S.; Olliaro P.; Garner P.; Artemisinin-based combination therapy for treating uncomplicated malaria. Cochrane Database Syst Rev 2009","journal-title":"Cochrane Database Syst Rev"},{"key":"ref=22","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1517\/13543784.9.8.1815","volume":"9","author":"Price R.N.","year":"2000","unstructured":"Price R.N.; Artemisinin drugs: Novel antimalarial agents. Expert Opin Investig Drugs 2000,9,1815-1827","journal-title":"Expert Opin Investig Drugs"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1056\/NEJMc0805011","volume":"359","author":"Noedl H.","year":"2008","unstructured":"Noedl H.; Se Y.; Schaecher K.; Smith B.L.; Socheat D.; Fukuda M.M.; Evidence of artemisinin-resistant malaria in Western Cambodia. N Engl J Med 2008,359,2619-2620","journal-title":"N Engl J Med"},{"key":"ref=24","doi-asserted-by":"crossref","first-page":"465","DOI":"10.7883\/yoken.65.465","volume":"65","author":"Mita T.","year":"2012","unstructured":"Mita T.; Tanabe K.; Evolution of Plasmodium falciparum drug resistance: Implications for the development and containment of artemisinin resistance. Jpn J Infect Dis 2012,65,465-475","journal-title":"Jpn J Infect Dis"},{"key":"ref=25","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1056\/NEJMoa0808859","volume":"361","author":"Dondorp A.M.","year":"2009","unstructured":"Dondorp A.M.; Nosten F.; Yi P.; Das D.; Phyo A.P.; Tarning J.; Lwin K.M.; Ariey F.; Hanpithakpong W.; Lee S.J.; Ringwald P.; Silamut K.; Imwong M.; Chotivanich K.; Lim P.; Herdman T.; An S.S.; Yeung S.; Singhasivanon P.; Day N.P.J.; Lindegardh N.; Socheat D.; White N.J.; Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med 2009,361,455-467","journal-title":"N Engl J Med"},{"key":"ref=26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12936-016-1206-9","volume":"15","author":"Paloque L.","year":"2016","unstructured":"Paloque L.; Ramadani A.P.; Mercereau-Puijalon O.; Augereau J-M.; Benoit-Vical F.; \n                        Plasmodium falciparum: Multifaceted resistance to artemisinins. Malar J 2016,15,1-12","journal-title":"Malar J"},{"key":"ref=27","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1111\/1469-0691.12316","volume":"19","author":"Wongsrichanalai C.","year":"2013","unstructured":"Wongsrichanalai C.; Sibley C.H.; Fighting drug-resistant Plasmodium falciparum: The challenge of artemisinin resistance. Clin Microbiol Infect 2013,19,908-916","journal-title":"Clin Microbiol Infect"},{"key":"ref=28","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1039\/C5OB02600H","volume":"14","author":"Kumar R.","year":"2016","unstructured":"Kumar R.; Kumar I.; Sharma R.; Sharma U.; Catalyst and solvent-free alkylation of quinoline N-oxides with olefins: A direct access to quinoline-substituted [small alpha]-hydroxy carboxylic derivatives. Org Biomol Chem 2016,14,2613-2617","journal-title":"Org Biomol Chem"},{"key":"ref=29","doi-asserted-by":"crossref","first-page":"7519","DOI":"10.1002\/ejoc.201501246","volume":"2015","author":"Sharma R.","year":"2015","unstructured":"Sharma R.; Kumar R.; Kumar I.; Sharma U.; RhIII-catalyzed dehydrogenative coupling of quinoline N-oxides with alkenes: N-oxide as traceless directing group for remote C\u2013H activation. Eur J Org Chem 2015,2015,7519-7528","journal-title":"Eur J Org Chem"},{"key":"ref=30","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/35005132","volume":"404","author":"Pagola S.","year":"2000","unstructured":"Pagola S.; Stephens P.W.; Bohle D.S.; Kosar A.D.; Madsen S.K.; The structure of malaria pigment [beta]-haematin. Nature 2000,404,307-310","journal-title":"Nature"},{"key":"ref=31","doi-asserted-by":"crossref","first-page":"9138","DOI":"10.1073\/pnas.0502368102","volume":"102","author":"Pandey K.C.","year":"2005","unstructured":"Pandey K.C.; Wang S.X.; Sijwali P.S.; Lau A.L.; McKerrow J.H.; Rosenthal P.J.; The Plasmodium falciparum cysteine protease falcipain-2 captures its substrate, hemoglobin, via a unique motif. Proc Natl Acad Sci USA 2005,102,9138-9143","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=32","doi-asserted-by":"crossref","first-page":"4384","DOI":"10.1073\/pnas.0307720101","volume":"101","author":"Sijwali P.S.","year":"2004","unstructured":"Sijwali P.S.; Rosenthal P.J.; Gene disruption confirms a critical role for the cysteine protease falcipain-2 in hemoglobin hydrolysis by Plasmodium falciparum. Proc Natl Acad Sci USA 2004,101,4384-4389","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=33","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1146\/annurev.micro.51.1.97","volume":"51","author":"Francis S.E.","year":"1997","unstructured":"Francis S.E.; Sullivan D.J.; Goldberg D.E.; Hemoglobin metabolism in the malaria parasite Plasmodium Falciparum. Annu Rev Microbiol 1997,51,97-123","journal-title":"Annu Rev Microbiol"},{"key":"ref=34","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1126\/science.781840","volume":"193","author":"Trager W.","year":"1976","unstructured":"Trager W.; Jensen J.B.; Human malaria parasites in continuous culture. Science 1976,193,673-675","journal-title":"Science"},{"key":"ref=35","doi-asserted-by":"crossref","first-page":"418","DOI":"10.2307\/3280287","volume":"65","author":"Lambros C.","year":"1979","unstructured":"Lambros C.; Vanderberg J.P.; Synchronization of Plasmodium falciparum erythrocytic stages in culture. J Parasitol 1979,65,418-420","journal-title":"J Parasitol"},{"key":"ref=36","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1128\/AAC.48.5.1803-1806.2004","volume":"48","author":"Smilkstein M.","year":"2004","unstructured":"Smilkstein M.; Sriwilaijaroen N.; Kelly J.X.; Wilairat P.; Riscoe M.; Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening. Antimicrob Agents Chemother 2004,48,1803-1806","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=37","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"Morris G.M.","year":"2009","unstructured":"Morris G.M.; Huey R.; Lindstrom W.; Sanner M.F.; Belew R.K.; Goodsell D.S.; Olson A.J.; AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J Comput Chem 2009,30,2785-2791","journal-title":"J Comput Chem"},{"key":"ref=38","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1039\/C6MB00182C","volume":"12","author":"Rajendran V.","year":"2016","unstructured":"Rajendran V.; Structural analysis of oncogenic mutation of isocitrate dehydrogenase 1. Mol Biosyst 2016,12,2276-2287","journal-title":"Mol Biosyst"},{"key":"ref=39","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1021\/ct700301q","volume":"4","author":"Hess B.","year":"2008","unstructured":"Hess B.; Kutzner C.; van der Spoel D.; Lindahl E.; GROMACS 4: Algorithms for highly efficient, load-balanced, and scalable molecular simulation. J Chem Theory Comput 2008,4,435-447","journal-title":"J Chem Theory Comput"},{"key":"ref=40","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/jcc.20291","volume":"26","author":"Van der Spoel D.","year":"2005","unstructured":"Van der Spoel D.; Lindahl E.; Hess B.; Groenhof G.; Mark A.E.; Berendsen H.J.C.; GROMACS: Fast, flexible, and free. J Comput Chem 2005,26,1701-1718","journal-title":"J Comput Chem"},{"key":"ref=41","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0009-3084(02)00106-8","volume":"120","author":"Baran M.","year":"2002","unstructured":"Baran M.; Mazerski J.; Molecular modelling of membrane sterols with the use of the GROMOS 96 force field. Chem Phys Lipids 2002,120,21-31","journal-title":"Chem Phys Lipids"},{"key":"ref=42","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1021\/jm8013663","volume":"52","author":"Kerr I.D.","year":"2009","unstructured":"Kerr I.D.; Lee J.H.; Pandey K.C.; Harrison A.; Sajid M.; Rosenthal P.J.; Brinen L.S.; Structures of falcipain-2 and falcipain-3 bound to small molecule inhibitors: Implications for substrate specificity. J Med Chem 2009,52,852-857","journal-title":"J Med Chem"},{"key":"ref=43","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/protein\/8.2.127","volume":"8","author":"Wallace A.C.","year":"1995","unstructured":"Wallace A.C.; Laskowski R.A.; Thornton J.M.; LIGPLOT: A program to generate schematic diagrams of protein-ligand interactions. Protein Eng 1995,8,127-134","journal-title":"Protein Eng"},{"key":"ref=44","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/07391102.2012.759885","volume":"32","author":"Rajendran V.","year":"2014","unstructured":"Rajendran V.; Sethumadhavan R.; Drug resistance mechanism of PncA in Mycobacterium tuberculosis. J Biomol Struct Dyn 2014,32,209-221","journal-title":"J Biomol Struct Dyn"},{"key":"ref=45","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/07391102.2011.10507379","volume":"29","author":"Purohit R.","year":"2011","unstructured":"Purohit R.; Rajendran V.; Sethumadhavan R.; Studies on adaptability of binding residues flap region of TMC-114 resistance HIV-1 protease mutants. J Biomol Struct Dyn 2011,29,137-152","journal-title":"J Biomol Struct Dyn"},{"key":"ref=46","doi-asserted-by":"crossref","first-page":"8872","DOI":"10.1002\/anie.200703758","volume":"46","author":"Kanyiva K.S.","year":"2007","unstructured":"Kanyiva K.S.; Nakao Y.; Hiyama T.; Nickel-catalyzed addition of pyridine-N-oxides across alkynes. Angew Chem Int Ed 2007,46,8872-8874","journal-title":"Angew Chem Int Ed"},{"key":"ref=47","doi-asserted-by":"crossref","first-page":"9254","DOI":"10.1021\/ja8026295","volume":"130","author":"Cho S.H.","year":"2008","unstructured":"Cho S.H.; Hwang S.J.; Chang S.; Palladium-catalyzed C\u2212H functionalization of pyridine N-oxides: Highly selective alkenylation and direct arylation with unactivated arenes. J Am Chem Soc 2008,130,9254-9256","journal-title":"J Am Chem Soc"},{"key":"ref=48","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1021\/ja808332k","volume":"131","author":"Campeau L-C.","year":"2009","unstructured":"Campeau L-C.; Stuart D.R.; Leclerc J-P.; Bertrand-Laperle M.; Villemure E.; Sun H-Y.; Lasserre S.; Guimond N.; Lecavallier M.; Fagnou K.; Palladium-catalyzed direct arylation of azine and azole N-oxides: Reaction development, scope and applications in synthesis. J Am Chem Soc 2009,131,3291-3306","journal-title":"J Am Chem Soc"},{"key":"ref=49","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1039\/C0OB00740D","volume":"9","author":"Araki Y.","year":"2011","unstructured":"Araki Y.; Kobayashi K.; Yonemoto M.; Kondo Y.; Functionalisation of heteroaromatic N-oxides using organic superbase catalyst. Org Biomol Chem 2011,9,78-80","journal-title":"Org Biomol Chem"},{"key":"ref=50","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1002\/anie.201200120","volume":"51","author":"Ryu J.","year":"2012","unstructured":"Ryu J.; Cho S.H.; Chang S.; A Versatile rhodium(I) catalyst system for the addition of heteroarenes to both alkenes and alkynes by a C-H bond activation. Angew Chem Int Ed 2012,51,3677-3681","journal-title":"Angew Chem Int Ed"},{"key":"ref=51","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1002\/adsc.201300111","volume":"355","author":"Wu Z.","year":"2013","unstructured":"Wu Z.; Pi C.; Cui X.; Bai J.; Wu Y.; Direct C-2 alkylation of quinoline N-oxides with ethers via palladium-catalyzed dehydrogenative cross-coupling reaction. Adv Synth Catal 2013,355,1971-1976","journal-title":"Adv Synth Catal"},{"key":"ref=52","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1021\/ol400178k","volume":"15","author":"Wu Z.","year":"2013","unstructured":"Wu Z.; Song H.; Cui X.; Pi C.; Du W.; Wu Y.; Sulfonylation of quinoline N-oxides with aryl sulfonyl chlorides via copper-catalyzed C-H bonds activation. Org Lett 2013,15,1270-1273","journal-title":"Org Lett"},{"key":"ref=53","doi-asserted-by":"crossref","first-page":"6900","DOI":"10.1039\/c3cc43947j","volume":"49","author":"Chen X.","year":"2013","unstructured":"Chen X.; Zhu C.; Cui X.; Wu Y.; Direct 2-acetoxylation of quinoline N-oxides via copper catalyzed C-H bond activation. Chem Commun 2013,49,6900-6902","journal-title":"Chem Commun"},{"key":"ref=54","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1021\/ol500183w","volume":"16","author":"Zhu C.","year":"2014","unstructured":"Zhu C.; Yi M.; Wei D.; Chen X.; Wu Y.; Cui X.; Copper-catalyzed direct amination of quinoline N-oxides via C-H bond activation under mild conditions. Org Lett 2014,16,1840-1843","journal-title":"Org Lett"},{"key":"ref=55","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1002\/adsc.201301065","volume":"356","author":"Chen X.","year":"2014","unstructured":"Chen X.; Li X.; Qu Z.; Ke D.; Qu L.; Duan L.; Mai W.; Yuan J.; Chen J.; Zhao Y.; H-phosphonate-mediated amination of quinoline N-oxides with tertiary amines: A mild and metal-free synthesis of 2-dialkylaminoquinolines. Adv Synth Catal 2014,356,1979-1985","journal-title":"Adv Synth Catal"},{"key":"ref=56","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1002\/adsc.201400203","volume":"356","author":"Yan G.","year":"2014","unstructured":"Yan G.; Borah A.J.; Yang M.; Recent advances in catalytic functionalization of N-oxide compounds via C-H bond activation. Adv Synth Catal 2014,356,2375-2394","journal-title":"Adv Synth Catal"},{"key":"ref=57","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1080\/01614940.2015.1058623","volume":"57","author":"Sharma R.","year":"2015","unstructured":"Sharma R.; Thakur K.; Kumar R.; Kumar I.; Sharma U.; Distant C-H activation\/functionalization: A new horizon of selectivity beyond proximity. Catal Rev 2015,57,345-405","journal-title":"Catal Rev"},{"key":"ref=58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12936-015-0564-z","volume":"14","author":"Kaushik N.K.","year":"2015","unstructured":"Kaushik N.K.; Bagavan A.; Rahuman A.A.; Zahir A.A.; Kamaraj C.; Elango G.; Jayaseelan C.; Kirthi A.V.; Santhoshkumar T.; Marimuthu S.; Rajakumar G.; Tiwari S.K.; Sahal D.; Evaluation of antiplasmodial activity of medicinal plants from North Indian Buchpora and South Indian Eastern Ghats. Malar J 2015,14,1-8","journal-title":"Malar J"},{"key":"ref=59","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2174\/1874104501105010011","volume":"5","author":"Vald\u00e9s A.F-C.","year":"2011","unstructured":"Vald\u00e9s A.F-C.; Acridine and acridinones: Old and new structures with antimalarial activity. Open Med Chem J 2011,5,11-20","journal-title":"Open Med Chem J"},{"key":"ref=60","doi-asserted-by":"crossref","first-page":"5392","DOI":"10.1073\/pnas.1218412110","volume":"110","author":"Chugh M.","year":"2013","unstructured":"Chugh M.; Sundararaman V.; Kumar S.; Reddy V.S.; Siddiqui W.A.; Stuart K.D.; Malhotra P.; Protein complex directs hemoglobin-to-hemozoin formation in Plasmodium falciparum. Proc Natl Acad Sci USA 2013,110,5392-5397","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/166256","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,10]],"date-time":"2019-11-10T18:53:12Z","timestamp":1573411992000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/166256\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,14]]},"references-count":60,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,10,14]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573406414666181015144413","relation":{},"ISSN":["1573-4064"],"issn-type":[{"value":"1573-4064","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10,14]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-04-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-09-02","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-10-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-10-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}